UBS (Lux) Equity Fund - Biotech Q Fonds
308,88
USD
+0,68
USD
+0,22
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,88% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,80% |
| Neurocrine Biosciences Inc | US64125C1099 | 6,44% |
| Guardant Health Inc | US40131M1099 | 4,88% |
| AbbVie Inc | US00287Y1091 | 4,82% |
| Gilead Sciences Inc | US3755581036 | 4,21% |
| Amgen Inc | US0311621009 | 3,79% |
| Moderna Inc | US60770K1079 | 3,51% |
| Denali Therapeutics Inc | US24823R1059 | 3,49% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,12% |
| Sonstige | 49,05% |